Robert L Atmar Selected Research

Influenza Vaccines (Influenza Vaccine)

1/2020	Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season.
1/2016	Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.
7/2015	Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.
1/2012	Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.
2/2010	A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects.
10/2008	Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.
5/2006	Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons.
2/2006	Influenza vaccine in patients with asthma.
11/2004	Inactivated influenza vaccination for people with spinal cord injury.
4/2004	Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert L Atmar Research Topics

Disease

53	Infections 01/2024 - 05/2002
28	Human Influenza (Influenza) 11/2021 - 04/2004
20	Gastroenteritis 04/2024 - 04/2007
12	COVID-19 07/2023 - 01/2020
8	Caliciviridae Infections 05/2023 - 11/2007
4	Virus Diseases (Viral Diseases) 12/2020 - 06/2003
3	Diarrhea 01/2023 - 03/2015
3	Respiratory Tract Infections (Respiratory Tract Infection) 12/2021 - 06/2010
3	Influenza in Birds (Avian Flu) 12/2020 - 11/2006
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2023 - 05/2023
2	Ebola Hemorrhagic Fever 02/2022 - 01/2021
2	Breakthrough Infections 01/2022 - 10/2021
2	Dengue (Dengue Fever) 12/2021 - 01/2019
2	Pneumonia (Pneumonitis) 12/2021 - 06/2010
2	Genetic Predisposition to Disease (Genetic Predisposition) 10/2021 - 03/2010
2	Hypersensitivity (Allergy) 01/2021 - 01/2012
2	Vaccinia 01/2017 - 03/2007
2	Chronic Obstructive Pulmonary Disease (COPD) 06/2010 - 10/2003
2	Asthma (Bronchial Asthma) 02/2006 - 04/2004
2	Immune Reconstitution Inflammatory Syndrome 04/2005 - 05/2002
1	Communicable Diseases (Infectious Diseases) 04/2024
1	Urinary Tract Infections (Urinary Tract Infection) 01/2024
1	Diabetes Mellitus 01/2024
1	Hypertension (High Blood Pressure) 01/2024
1	Substance-Related Disorders (Drug Abuse) 11/2023
1	Hematologic Neoplasms (Hematological Malignancy) 03/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Schistosomiasis mansoni 01/2023
1	HIV Infections (HIV Infection) 11/2022
1	Mpox (monkeypox) 11/2022
1	Bacteriuria 10/2022
1	Disease Progression 07/2022
1	Yellow Fever 12/2021
1	Severe Dengue 12/2021

Drug/Important Bio-Agent (IBA)

53	VaccinesIBA 11/2023 - 06/2004
15	Blood Group Antigens (Blood Groups)IBA 04/2024 - 05/2002
12	AntigensIBA 06/2023 - 04/2004
10	Antiviral Agents (Antivirals)IBA 10/2023 - 06/2004
10	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020 - 04/2004
7	Immunoglobulin G (IgG)IBA 12/2021 - 06/2003
7	Hemagglutinins (Hemagglutinin)IBA 01/2019 - 11/2006
6	AntibodiesIBA 06/2023 - 06/2013
5	Polysaccharides (Glycans)IBA 04/2024 - 06/2013
5	Neutralizing AntibodiesIBA 07/2023 - 03/2007
5	Proteins (Proteins, Gene)FDA Link 07/2023 - 12/2012
5	remdesivirIBA 12/2022 - 11/2020
4	Immunoglobulin A (IgA)IBA 05/2017 - 08/2015
3	2019-nCoV Vaccine mRNA-1273IBA 07/2023 - 10/2021
3	Ad26COVS1IBA 07/2023 - 10/2021
3	BNT162 VaccineIBA 07/2023 - 10/2021
3	COVID-19 VaccinesIBA 01/2022 - 05/2021
3	CytokinesIBA 12/2020 - 05/2007
3	RNA (Ribonucleic Acid)IBA 01/2019 - 11/2007
3	Neuraminidase (Sialidase)IBA 03/2013 - 02/2010
2	Glycoproteins (Glycoprotein)IBA 04/2024 - 01/2021
2	FluoroquinolonesIBA 01/2024 - 01/2008
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2024 - 01/2020
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2024 - 01/2020
2	nitazoxanide (NTZ)FDA Link 10/2023 - 05/2023
2	EpitopesIBA 10/2023 - 06/2023
2	Messenger RNA (mRNA)IBA 07/2023 - 10/2003
2	Rotavirus VaccinesIBA 01/2023 - 07/2010
2	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 06/2007
2	baricitinibIBA 07/2022 - 01/2022
2	Oxygen (Dioxygen)IBA 01/2022 - 12/2021
2	InterferonsIBA 12/2021 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 12/2020 - 05/2007
2	Inactivated VaccinesIBA 12/2020 - 01/2009
2	CarbohydratesIBA 11/2020 - 06/2004
2	EnzymesIBA 01/2020 - 07/2011
2	FucosyltransferasesIBA 01/2019 - 11/2007
2	Blocking AntibodiesIBA 05/2017 - 10/2010
2	Subunit VaccinesIBA 01/2012 - 11/2006
2	MF59 oil emulsionIBA 01/2009 - 11/2006
2	Interleukin-8 (Interleukin 8)IBA 05/2007 - 10/2003
2	ChemokinesIBA 05/2007 - 10/2003
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2024
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2024
1	Phosphates (Orthophosphate)IBA 01/2024
1	JTE 013IBA 01/2024
1	NVX-CoV2373 adjuvated lipid nanoparticleIBA 07/2023
1	ClathrinIBA 01/2023
1	AcidsIBA 01/2023
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 07/2022
1	mRNA VaccinesIBA 07/2022
1	Ebola VaccinesIBA 02/2022
1	molnupiravirIBA 01/2022
1	nirmatrelvir and ritonavir drug combinationIBA 01/2022
1	Anti-Infective Agents (Microbicides)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022

Therapy/Procedure

6	Therapeutics 01/2023 - 04/2004
2	Off-Label Use 10/2023 - 05/2023
2	Highly Active Antiretroviral Therapy (HAART) 04/2005 - 05/2002
1	Transplantation 03/2023
1	Art Therapy 11/2022
1	Noninvasive Ventilation 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2022